Cargando…
Serological response to COVID-19 vaccination in patients with cancer older than 80 years
Central studies carried out on vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-COV2) excluded patients receiving immunosuppressive therapy and those diagnosed with an immunosuppressive condition. Moreover, there are no data on vaccine efficacy regarding older patients with...
Autores principales: | Iacono, Daniela, Cerbone, Linda, Palombi, Lucia, Cavalieri, Elena, Sperduti, Isabella, Cocchiara, Rosario Andrea, Mariani, Bruno, Parisi, Gabriella, Garufi, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192957/ https://www.ncbi.nlm.nih.gov/pubmed/34175246 http://dx.doi.org/10.1016/j.jgo.2021.06.002 |
Ejemplares similares
-
Longitudinal dynamics of SARS-CoV-2 anti–receptor binding domain IgG antibodies in a wide population of health care workers after BNT162b2 vaccination
por: Bordi, Licia, et al.
Publicado: (2022) -
Impact of preoperative management in patients older than 80 years requiring cholecystectomy
por: Shin, Da-Kyum, et al.
Publicado: (2018) -
Morphologic evaluation of megakaryocytes in immune thrombocytopenia patients older than 80 years
por: Demirci, Ufuk, et al.
Publicado: (2023) -
Acute myocardial infarction in patients older than 80 years: 3 years later
por: Lorente, L, et al.
Publicado: (2002) -
Risk factors of cervical surgery related complications in patients older than 80 years
por: Tamai, Koji, et al.
Publicado: (2017)